Evolutionary Genomics, Inc. Deferred Tax Assets, Net of Valuation Allowance
Evolutionary Genomics, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $308.85 thousand as of 2022-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2023-03-09
- 2022-12-31: Deferred Tax Assets, Net of Valuation Allowance $308.85K.
- 2021-12-31: Deferred Tax Assets, Net of Valuation Allowance $652.14K.
- 2020-12-31: Deferred Tax Assets, Net of Valuation Allowance $903.28K.
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $10.86K.
| Period end | Deferred Tax Assets, Net of Valuation Allowance | Deferred Tax Assets, Net of Valuation Allowance as first filed |
|---|---|---|
| 2022-12-31 | $308.85K 10-K · filed 2023-03-09 | |
| 2021-12-31 | $652.14K 10-K · filed 2023-03-09 | |
| 2020-12-31 | $903.28K 10-K · filed 2022-03-22 | |
| 2019-12-31 | $10.86K 10-K · filed 2021-03-31 | |
| 2018-12-31 | $16.46K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $1.36K 10-K · filed 2019-04-01 | $1.36K 10-K · filed 2018-03-05 |
| 2016-12-31 | $6.00K 10-K · filed 2018-03-05 | |
| 2015-12-31 | $6.00K 10-K · filed 2017-02-10 | |
| 2014-12-31 | $9.00K 10-K · filed 2016-02-19 |